Literature DB >> 14532150

New strategies to control inflammatory synovitis: interleukin 15 and beyond.

I B McInnes1, J A Gracie, M Harnett, W Harnett, F Y Liew.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14532150      PMCID： PMC1766739          DOI： 10.1136/ard.62.suppl_2.ii51

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  19 in total

1.  A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.

Authors:  J M Bathon; R W Martin; R M Fleischmann; J R Tesser; M H Schiff; E C Keystone; M C Genovese; M C Wasko; L W Moreland; A L Weaver; J Markenson; B K Finck
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

3.  Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis.

Authors:  Fionula M Brennan; Amanda L Hayes; Cathleen J Ciesielski; Patricia Green; Brian M J Foxwell; Marc Feldmann
Journal:  Arthritis Rheum       Date:  2002-01

Review 4.  Lymphatic filariasis: parallels between the immunology of infection in humans and mice.

Authors:  R A Lawrence; E Devaney
Journal:  Parasite Immunol       Date:  2001-07       Impact factor: 2.280

5.  Serum cytokines in different histological variants of rheumatoid arthritis.

Authors:  P A Klimiuk; S Sierakowski; R Latosiewicz; B Cylwik; J Skowronski; J Chwiecko
Journal:  J Rheumatol       Date:  2001-06       Impact factor: 4.666

6.  Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation.

Authors:  M Sen; M Chamorro; J Reifert; M Corr; D A Carson
Journal:  Arthritis Rheum       Date:  2001-04

Review 7.  Role of interleukin 15 and interleukin 18 in inflammatory response.

Authors:  F Y Liew; I B McInnes
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

8.  An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection.

Authors:  S Ferrari-Lacraz; X X Zheng; Y S Kim; Y Li; W Maslinski; X C Li; T B Strom
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

9.  Interferon-gamma:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue.

Authors:  Michael P Scola; Susan D Thompson; Hermine I Brunner; Monica K Tsoras; David Witte; Marc A Van Dijk; Alexei A Grom; Murray H Passo; David N Glass
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

10.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.

Authors:  K H Grabstein; J Eisenman; K Shanebeck; C Rauch; S Srinivasan; V Fung; C Beers; J Richardson; M A Schoenborn; M Ahdieh
Journal:  Science       Date:  1994-05-13       Impact factor: 47.728
View more
  8 in total

1.  Clinical significance of IL-18, IL-15, IL-12 and TNF-alpha measurement in rheumatoid arthritis.

Authors:  Ljiljana Petrovic-Rackov; Nada Pejnovic
Journal:  Clin Rheumatol       Date:  2005-12-14       Impact factor: 2.980

2.  Rituximab-induced interleukin-15 reduction associated with clinical improvement in rheumatoid arthritis.

Authors:  César Díaz-Torné; M Angels Ortiz de Juana; Carme Geli; Elisabet Cantó; Ana Laiz; Héctor Corominas; Jordi Casademont; Josep M de Llobet; Cándido Juárez; César Díaz-López; Sílvia Vidal
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

Review 3.  Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis.

Authors:  Iain B McInnes; J Alastair Gracie
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

4.  Interleukin-15 stimulates macrophages to activate CD4+ T cells: a role in the pathogenesis of rheumatoid arthritis?

Authors:  René Rückert; Katja Brandt; Martin Ernst; Kathleen Marienfeld; Elena Csernok; Claudia Metzler; Vadim Budagian; Elena Bulanova; Ralf Paus; Silvia Bulfone-Paus
Journal:  Immunology       Date:  2008-06-13       Impact factor: 7.397

Review 5.  Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis.

Authors:  Iain B McInnes; J Alastair Gracie
Journal:  Curr Pain Headache Rep       Date:  2005-12

6.  An activation-induced IL-15 isoform is a natural antagonist for IL-15 function.

Authors:  Lei Zhao; Bo Hu; Yinsheng Zhang; Yuan Song; Dandan Lin; Yonghao Liu; Yu Mei; Dedy Sandikin; Weiping Sun; Min Zhuang; Haiyan Liu
Journal:  Sci Rep       Date:  2016-05-11       Impact factor: 4.379

7.  Smac127 Has Proapoptotic and Anti-Inflammatory Effects on Rheumatoid Arthritis Fibroblast-Like Synoviocytes.

Authors:  D Lattuada; R Gualtierotti; K Crotta; P Seneci; F Ingegnoli; C Corradini; R Viganò; O Marelli; C Casnici
Journal:  Mediators Inflamm       Date:  2016-02-17       Impact factor: 4.711

8.  Proinflammatory soluble interleukin-15 receptor alpha is increased in rheumatoid arthritis.

Authors:  Ana Cecilia Machado Diaz; Araceli Chico Capote; Celia Aurora Arrieta Aguero; Yunier Rodríguez Alvarez; Diana García Del Barco Herrera; Miguel Estévez Del Toro; Gerardo E Guillen Nieto; Alicia Santos Savio
Journal:  Arthritis       Date:  2012-07-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.